Citizens Cuts Brown & Brown (BRO) Price Target to $75

Citizens maintains its Market Outperform rating on Brown & Brown, setting a price target of $75 as the stock trades below this level, a 9.22% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:20 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Citizens cut its price target on Brown & Brown, Inc. ($BRO) to $75 from $78 on October 12, 2026, and rates the stock "Market Outperform".

Since the rating, $BRO is up 9.0% to date (from the $63.65 close on Oct 12, 2026).

BRO Brown & Brown, Inc.

$69.40 -9.92% year to date

Daily close · Oct 16, 2026

Key Points

On October 12, 2026, Citizens reiterated its Market Outperform rating on Brown & Brown, Inc. with a price target of $75.0.
Citizens's $75 price target implies 9.22% upside from Brown & Brown, Inc.'s ($BRO) current $68.67 share price.
The stock was recently trading around $68.67, which is about 8.4% below the new target.
Citizens is among several firms maintaining positive views on Brown & Brown, as the insurance broker shows strong revenue growth.

Get $BRO trade alerts by text

We text you when insiders, Congress or big funds trade $BRO. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Brown & Brown, Inc. alert may contain errors. Disclosures

Citizens reiterated its Market Outperform rating on Brown & Brown, Inc. (NYSE: BRO) on October 12, 2026, setting a price target of $75. This marks a decrease from its prior target of $78. The stock was recently trading at $68.67, which is about 8.4% below the target.

Other Institutional Activity in Brown & Brown

Several other institutional investors have been active in Brown & Brown. BlackRock Inc. grew its holdings by 197,245 shares, ending with 22,113,344 shares worth about $1.53 billion. Vanguard Capital Management LLC added 20,812 shares to reach 18,941,212 shares valued at approximately $1.31 billion. Meanwhile, FMR, LLC increased its stake by 2,354,690 shares, totaling 18,405,749 shares worth about $1.28 billion.

Brown & Brown, Inc. Stock Up 5.6%

Brown & Brown shares are trading near $68.67, which is below the new price target of $75 set by Citizens. This suggests the stock might have room for growth if it can close the gap. The company's strong revenue growth of 32.4% year-over-year adds to the positive outlook.

12-month forecast

$BRO price target

Brown & Brown, Inc. daily closes and this analyst's $75 target. Not advice.

Recent Earnings

Brown & Brown reported trailing twelve-month revenue of approximately $6.66 billion and an EPS of $3.13. The next earnings report is scheduled for October 26, 2026. With a net margin of 18.1% and a return on equity of 10.0%, the company shows solid profitability metrics.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 30/100

Reported Apr 27, 2026

Forward outlook
6 target cuts vs 0 raises.
EPS & revenue
EPS beat estimates by 0.8%. Revenue missed estimates by 1.3%.
Profit surprise
EBITDA missed by 9 percent. Operating income missed by 4 percent.
Pre-earnings setup
Expectations were about average.
Analyst signal
1 upgrade, 6 target cuts.
Earnings quality
Gross margin up 1.6 points. Operating margin down 4.6 points. Positive free cash flow.

Earnings Call Summary

Brown & Brown delivered $1.9 billion in revenue with earnings per share of $1.39, beating expectations slightly despite missing on top-line. The first quarter was strong on margins at 38.5 percent and cash flow at $260 million, driven by large increases in contingent commissions of $54 million from strong underwriting performance. However, organic growth remained weak at only 2.2 percent including contingents and flat excluding them, hurt by property rates declining 15 to 35 percent and a shift in the pharmacy consulting business model. Management is integrating Accession, repositioning the Retail sales model for better specialization, and investing heavily in AI capabilities to improve customer experience and automate routine work, with early examples showing 25 percent of specialty submissions now processed by AI agents.

Guidance Management did not provide explicit full-year revenue or earnings guidance. They indicated organic growth should improve each quarter in 2026 compared to the first quarter, with back-half growth potentially reaching about 2.5 percent. Specialty Distribution is expected to be relatively flat in Q2 due to heavy property placements, then improve in the second half as the Accession business contributes.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Insider Buying and Selling at Brown & Brown, Inc.

Two insiders have bought shares recently. H Palmer Proctor Jr, a Director, purchased 2,000 shares on May 5, 2026, at an average price of $57.10, totaling about $114,200. Joia M Johnson, also a Director, bought 860 shares on June 9, 2026, for about $49,923 at an average price of $58.05.

Analysts Set New Price Targets

On October 12, 2026, Wells Fargo maintained an Equal-Weight rating with a target of $68.0, while TD Cowen initiated coverage with a Buy rating and a target of $82.0. Earlier, Mizuho and Barclays maintained their ratings at Outperform and Equal-Weight, respectively, with targets of $78.0 and $71.0.

About Brown & Brown

Brown & Brown, Inc. specializes in marketing and selling insurance products and services across the U.S. and internationally. It operates through Retail and Specialty Distribution segments, providing a wide range of insurance and risk management services. This reiteration of a Market Outperform rating by Citizens suggests confidence in its ongoing performance.

Bottom Line

Investors should keep an eye on Brown & Brown's upcoming earnings report on October 26, 2026, as well as any further analyst updates. The stock's current trading level presents a gap to the recently set price target, indicating potential for movement in the near future.